Qbd-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for alzheimer’s therapeutics

HIGHLIGHTS

  • who: Manish Kumar from the Icahn School of Medicine at Mount Sinai, United States Hong Kong Baptist University, Hong have published the research work: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics, in the Journal: (JOURNAL)
  • what: In this study, RT-loaded SLNs for intranasal administration were developed using glyceryl monostearate, polysorbate 80 and 90% methanol by employing hot homogenization and a modified solvent-evaporation process. The aim of this technique is to determine the effect of critical process parameters (CPPs) and critical material . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?